Pharmacokinetics of glycyrrhizin after intravenous administration to rats
- PMID: 1432649
- DOI: 10.1002/jps.2600810925
Pharmacokinetics of glycyrrhizin after intravenous administration to rats
Abstract
A simple high-performance liquid chromatographic method was developed to study the pharmacokinetics of glycyrrhizin in the rat after bolus intravenous administration at a dose of 20, 50, or 100 mg/kg. The decline in the concentration of glycyrrhizin in plasma was generally biexponential at each dose, but the terminal disposition became much slower as the dose was increased. A greater-than-proportional increase in the glycyrrhizin concentration in plasma was observed with an increase in the dose, a result suggesting a dose-dependent glycyrrhizin disposition. The disposition of drug in plasma at each dose fitted well to a two-compartment pharmacokinetic model. The apparent total body clearance decreased significantly with increases in the dose. On the other hand, the apparent distribution volume after intravenous administration was unaffected by the dose. The results indicate that the pharmacokinetics of glycyrrhizin is nonlinear.
Similar articles
-
Pharmacokinetics of glycyrrhetic acid, a major metabolite of glycyrrhizin, in rats.Chem Pharm Bull (Tokyo). 1989 Sep;37(9):2509-13. doi: 10.1248/cpb.37.2509. Chem Pharm Bull (Tokyo). 1989. PMID: 2605701
-
Pharmacokinetic profile of glycyrrhizin in healthy volunteers by a new high-performance liquid chromatographic method.J Pharm Sci. 1992 Oct;81(10):1042-6. doi: 10.1002/jps.2600811018. J Pharm Sci. 1992. PMID: 1432618
-
Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability.Biol Pharm Bull. 1995 Feb;18(2):337-41. doi: 10.1248/bpb.18.337. Biol Pharm Bull. 1995. PMID: 7742809
-
Analysis and pharmacokinetics of glycyrrhizic acid and glycyrrhetinic acid in humans and experimental animals.Steroids. 1994 Feb;59(2):121-6. doi: 10.1016/0039-128x(94)90088-4. Steroids. 1994. PMID: 8191540 Review.
-
Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate.Int J Toxicol. 2007;26 Suppl 2:79-112. doi: 10.1080/10915810701351228. Int J Toxicol. 2007. PMID: 17613133 Review.
Cited by
-
Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds.Phytother Res. 2008 Jun;22(6):709-24. doi: 10.1002/ptr.2362. Phytother Res. 2008. PMID: 18446848 Free PMC article. Review.
-
Ursolic Acid Ameliorates Inflammation in Cerebral Ischemia and Reperfusion Injury Possibly via High Mobility Group Box 1/Toll-Like Receptor 4/NFκB Pathway.Front Neurol. 2018 May 18;9:253. doi: 10.3389/fneur.2018.00253. eCollection 2018. Front Neurol. 2018. PMID: 29867706 Free PMC article.
-
Anti-Inflammation of Natural Components from Medicinal Plants at Low Concentrations in Brain via Inhibiting Neutrophil Infiltration after Stroke.Mediators Inflamm. 2016;2016:9537901. doi: 10.1155/2016/9537901. Epub 2016 Sep 5. Mediators Inflamm. 2016. PMID: 27688603 Free PMC article. Review.
-
Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease.Viruses. 2021 Apr 2;13(4):609. doi: 10.3390/v13040609. Viruses. 2021. PMID: 33918301 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources